|
|
|
Volumn 55, Issue 9, 2000, Pages 701-
|
|
Resorcylidene aminoguanidine improves the pathologically reduced fluidity of erythrocyte membranes in diabetes mellitus
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVANCED GLYCATION END PRODUCT;
AMINOGUANIDINE;
RESORCYLIDENE AMINOGUANIDINE;
UNCLASSIFIED DRUG;
GUANIDINE DERIVATIVE;
ADULT;
ARTICLE;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG MECHANISM;
ERYTHROCYTE DEFORMABILITY;
ERYTHROCYTE MEMBRANE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MEMBRANE FLUIDITY;
OXYGEN TRANSPORT;
PROTEIN CROSS LINKING;
PROTEIN GLYCOSYLATION;
ANISOTROPY;
BLOOD;
DRUG EFFECT;
IN VITRO STUDY;
INSULIN DEPENDENT DIABETES MELLITUS;
PHYSIOLOGY;
ANISOTROPY;
DIABETES MELLITUS, TYPE 1;
ERYTHROCYTE MEMBRANE;
GUANIDINES;
HUMANS;
MEMBRANE FLUIDITY;
|
|
EID: 0033811908
PISSN: 00317144
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (15)
|
